Global Anti-Viral Drug Therapy Market Outlook 2020-2030 - Top Major Players Gilead Sciences Inc, GlaxoSmithKline plc, Johnson & Johnson, AbbVie Inc., Merck & Co., Inc.

The Business Research Company’s Anti-Viral Drug Therapy Market - Opportunities And Strategies - Global Anti-Viral Drug Therapy Market Forecast To 2030

Avail up to 50% off on ALL research reports at: https://www.thebusinessresearchcompany.com/global-market-reports. Offer applies until Dec 31st.

The global anti-viral drug therapy market reached a value of nearly $46,456.4 million in 2019, having increased at a compound annual growth rate (CAGR) of 5.0% since 2015. The market is expected to grow from $46,456.4 million in 2019 to $ 61,571.9 million in 2020 at a rate of 32.5%. The growth is mainly due to the increase in number of COVID-19 cases. The market is then expected to grow at a CAGR of 8.3% from 2021 and reach $74,385.9 million in 2023. The market is expected to reach $ 87,230.5 million in 2025, and $ 130,125.3 million in 2030.

The key drivers of the anti-viral drug therapy market include:
The anti-viral drug therapy market is expected to benefit from the latest developments in drug discovery procedures such as stem cells and organ-on-chip (OOC) technologies. OOCs are micro-engineered biometric systems that simulate the activities, mechanics and physiological responses of organ systems. Drug trial processes such as target identification, validation, and screening are being executed through OOC and stem cell technologies. These technologies are considerably reducing the drug discovery costs and generating reliable predictions on drug efficiency and human safety. Another area of development is physiology-simulation modelling, in which the integrated physiology of the human organism, in both health and disease, is simulated through a computer program. Eli Lilly and Pfizer have adopted Amazon’s Elastic Compute Cloud (EC2) platform to conduct simulation models in early stages of the drug discovery process that are operational within hours, whereas traditional models take weeks to conduct simulations. The wide adoption of these technologies is expected to drive the anti-viral drug therapy market in the forecast period.

Browse Complete Report @ https://www.thebusinessresearchcompany.com/report/anti-viral-drug-therapy-market

Anti-Viral Drug Therapy Market Segmentation:-
By Drug Class - The anti-viral drug therapy market can be segmented by drug class into
a. DNA (Nucleotide) Polymerase Inhibitors
b. Reverse Transcriptase Inhibitors
c. Protease Inhibitors
d. Neuraminidase Inhibitors
e. Others
Reverse transcriptase inhibitors market was the largest segment of the anti-viral drug therapy market segmented by drug class, accounting for 50.0% of the total in 2019. Also, it is expected to be the fastest growing segment in the anti-viral drug therapy market segmented by drug class, at a CAGR of 20.0% during 2019-2023.

By Application - The anti-viral drug therapy market can be segmented by application into
a. HIV
b. Hepatitis
c. Herpes
d. Influenza
e. Others
The HIV market was the largest segment of the anti-viral drug therapy market segmented by application, accounting for 34.1% of the total in 2019. Going forward, the influenza segment is expected to be the fastest growing segment in the anti-viral drug therapy market segmented by application, at a CAGR of 14.5% during 2019-2023.

Request For A Sample Copy Of This Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=2831&type=smp

By Geography - The anti-viral drug therapy market is segmented into
1.North America
2.Western Europe
3.Asia Pacific
4.Eastern Europe
5.South America
6.Middle East
7.Africa

Some of the major key players involved in the anti-viral drug therapy market are
• Gilead Sciences Inc
• GlaxoSmithKline plc
• Johnson & Johnson
• AbbVie Inc.
• Merck & Co., Inc.

Place a DIRECT PURCHASE ORDER of the report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2831

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on Blog: http://blog.tbrc.info/

About US:
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets after WHO declared COVID-19 as a pandemic.

This release was published on openPR.